A comprehensive genomic study of HNSCC in 2015 showed 25% of mutated PIK3CA displayed concurrent amplification, with an additional 20% of tumours containing focal amplification without evidence of mutation. This evidence concerns the gene PIK3CA and head and neck squamous cell carcinoma.